THERMO FISHER SCIENTIFIC INC. (TMO) FY2026 Q2 P&L / Income Statement

2026-03-29 to 2026-06-27

Swipe to see the full flow
THERMO FISHER SCIENTIFIC INC. (TMO) FY2026 Q2 P&L / Income StatementIncome statement for 2026-03-29 through 2026-06-27. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.SOURCESREVENUEGROSSOPERATINGPRE-TAXNETLaboratory Products and Biopharma ServicesLife Sciences SolutionsAnalytical InstrumentsSpecialty DiagnosticsTotal revenuesGross profit (calculated)Cost of revenue (calculated)Cost of revenuesOperating incomeOperating expenses (calculated)Selling, general and administrative expensesResearch and development expensesRestructuring and other costsIncome before income taxesOther income (expense), net (calculated)Net incomeBenefit from/(provision for) income taxesEquity in earnings/(losses) of unconsolidated entitiesGross profit (calculated)Gross profit(calculated)$4.88 BTotal revenuesTotal revenues$11.99 BOperating incomeOperating income$2.09 BIncome before income taxesPretax income$1.92 BNet incomeNet income$1.74 BLaboratory Products and Biopharma ServicesLaboratory Productsand Biopharma Services$6.65 BOperating expenses (calculated)Operating expenses(calculated)$2.80 BBenefit from/(provision for) income taxesBenefitfrom/(provisionfor) income taxes$167.00 MSelling, general and administrative expensesSelling, general andadministrative expenses$2.33 BOther income (expense), net (calculated)Other income,net (calculated)−$163.00 MCost of revenue (calculated)Cost of revenue(calculated)$7.11 BLife Sciences SolutionsLife Sciences Solutions$2.36 BResearch and development expensesResearch anddevelopment expenses$364.00 MEquity in earnings/(losses) of unconsolidated entitiesEquity inearnings/(losses)of unconsolidated…−$15.00 MAnalytical InstrumentsAnalytical Instruments$1.80 BRestructuring and other costsRestructuring and other costs$98.00 MSpecialty DiagnosticsSpecialty Diagnostics$1.19 BCost of revenuesCost of revenues$7.11 B
Chart details

THERMO FISHER SCIENTIFIC INC. (TMO) FY2026 Q2 P&L / Income Statement

Income statement for 2026-03-29 through 2026-06-27. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Total revenues
11,994,000,000 US dollars
Cost of revenue (calculated)
7,112,000,000 US dollars
Gross profit (calculated)
4,882,000,000 US dollars
Operating expenses (calculated)
2,795,000,000 US dollars
Operating income
2,087,000,000 US dollars
Other income (expense), net (calculated)
negative 163,000,000 US dollars
Income before income taxes
1,924,000,000 US dollars
Benefit from/(provision for) income taxes
167,000,000 US dollars
Net income
1,741,000,000 US dollars
Life Sciences Solutions
2,355,000,000 US dollars
Analytical Instruments
1,799,000,000 US dollars
Specialty Diagnostics
1,188,000,000 US dollars
Laboratory Products and Biopharma Services
6,652,000,000 US dollars
Cost of revenues
7,112,000,000 US dollars
Selling, general and administrative expenses
2,333,000,000 US dollars
Research and development expenses
364,000,000 US dollars
Restructuring and other costs
98,000,000 US dollars
Equity in earnings/(losses) of unconsolidated entities
negative 15,000,000 US dollars. Reported below-tax contribution to net income.

Chart connections

  • Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
  • Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit, plus the explicitly reported below-tax contributions, equals net income.
  • Of which attributable to THERMO FISHER SCIENTIFIC INC.: $1.74 B; to noncontrolling interests: $5.00 M.
  • The amounts that make up net income come to $1,742.00 M and net income is $1,741.00 M; the $1.00 M difference is within the rounding of the filed amounts.
THERMO FISHER SCIENTIFIC INC. (TMO) FY2026 Q2 Revenue by Business Segment Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Gross margin

40.7%

Gross profit / revenue

Operating margin

17.4%

Operating profit / revenue

Cash conversion

122.1%

Operating cash / net income, same period

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!